Nexium Trial Begins

Wexler Wallace attorneys, along with co-counsel, will begin a six-week trial today in the District of Massachusetts over anticompetitive actions surrounding AstraZeneca’s blockbuster drug Nexium. The case, which is being tried in front of a jury and before the Honorable Judge William C. Young, was filed in 2012. At issue, plaintiffs allege AstraZeneca entered into non-competition agreements with a number of generic pharmaceutical manufacturers in order to delay market entry of generic versions of the drug. For more information about the case, please click here.